Peter MacCallum Cancer Centre
Australia Just Approved the First New Therapy for Chronic GVHD
Chronic graft-versus-host disease develops when donated stem cells attack the patient’s own body. It affects 40 to 50% of stem cell transplant recipients. In most cases three or more organs are involved. For patients who have already failed two lines of treatment, the options until now have been limited and the outcomes often poor. Australia…
